Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
about
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarctionPostinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart FailureMicroRNA-141 regulates the expression level of ICAM-1 on endothelium to decrease myocardial ischemia-reperfusion injury.Measuring Water Distribution in the Heart: Preventing Edema Reduces Ischemia-Reperfusion Injury.Microvascular obstruction assessed by 3-tesla magnetic resonance imaging in acute myocardial infarction is correlated with plasma troponin I levels.Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model.A Randomized Comparison between Everolimus-Eluting Stent and Cobalt Chromium Stent in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Using Routine Intravenous Eptifibatide: The X-MAN (XieImpact of Timing of Eptifibatide Administration on Preprocedural Infarct-Related Artery Patency in Acute STEMI Patients Undergoing Primary PCI.The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imagingMyocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMRCardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury.Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction.Serial assessment of the index of microcirculatory resistance during primary percutaneous coronary intervention comparing manual aspiration catheter thrombectomy with balloon angioplasty (IMPACT study): a randomised controlled pilot studyMultimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational studySecretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.Microvascular Resistance Predicts Myocardial Salvage and Infarct Characteristics in ST-Elevation Myocardial Infarction.ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activationTowards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.Diagnostic Ultrasound High Mechanical Index Impulses Restore Microvascular Flow in Peripheral Arterial ThromboembolismRecurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion.AMPK-mediated cardioprotection of atorvastatin relates to the reduction of apoptosis and activation of autophagy in infarcted rat hearts.Efficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting.Cardiovascular MRI for the assessment of heart failure: focus on clinical management and prognosis.Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications.Cardiovascular magnetic resonance imaging in ischemic heart disease.Angiogenesis in the infarcted myocardium.Imaging the myocardial microcirculation post-myocardial infarction.Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis?Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.Coronary microvascular dysfunction: mechanisms and functional assessment.CMR in Heart Failure.Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.Coronary microvascular obstruction in acute myocardial infarction.Role of Cardiac Magnetic Resonance Imaging in Myocardial Infarction.The challenges and impact of microvascular injury in ST-elevation myocardial infarction.Microvascular leakage in acute myocardial infarction: characterization by histology, biochemistry, and magnetic resonance imaging.Cardiac magnetic resonance imaging in heart failure: where the alphabet begins!Lactated Ringer's solution for preventing myocardial reperfusion injury.
P2860
Q26740252-F61439B1-664B-43E3-A518-809D6848A556Q26753845-40A664A7-BE2D-4F5F-977D-7603A45F58E5Q29347548-ED6E6FC6-8C8A-4407-8BCC-F26127C46668Q31149783-C79B7064-27FE-4D77-9B8D-4C94CE266E74Q33578251-BD67E48B-853C-4300-B942-CFB8D8C1E75BQ33704554-DDE1B83D-4167-4450-A9AD-F61EFFCCA253Q33848052-037E1BF5-AA6C-4A42-B8A8-3CFB87B54EE9Q34213126-EE54361C-A958-472B-9E5A-463B028C3376Q34507513-F5F57C84-0035-4B91-A782-38710C1B6C77Q34972257-4876CDBD-29B2-4E35-A080-A80268F27247Q35186568-C3B32F4A-26EB-439C-8D9A-E32B0258DBD6Q35240779-27361028-6C31-44B0-AB90-C91DB00B806AQ35640551-5965CD2D-0658-4C81-B029-79754ED6720CQ36205883-77F1630C-0E22-4911-9BC8-599CFC4627FAQ36233665-7A4FB126-6C4F-414D-824F-11C89E4710AAQ36366231-CB10D99C-C1C3-4C07-BE3E-BE2F68F1B6A0Q36409013-5E0C2356-E694-40DB-858A-B4F4ED27EE25Q36915712-FC53884B-2732-4BB6-8FC0-34548BBC8C49Q36984632-A1DF7AE9-D4E9-4E05-8CDF-CE09F115B87DQ37140881-4ECA4BF0-5AB7-4A59-A6A6-8A5030AEFB66Q37158344-8977AF1F-0935-46F6-A0A9-81CB95225BAFQ37291936-535CCDA8-3BCE-4948-8CE2-7B77055E9114Q37393408-82CAEC04-9CDB-466E-932F-161875107E85Q37708215-C69DF023-0C27-40DE-A060-F71BAA70F9E1Q37833012-D0F88458-26AF-4CEA-8F77-06F51F42965BQ37933583-7D1094A9-EFEF-438B-B527-AE00AC73C280Q38018564-493B3553-C8F5-47F3-B87B-7EB0A6D7F67DQ38032602-A5409298-0070-4B30-ADC0-A7BD3FCD177FQ38038533-88C12269-486E-4F28-B594-DFC438B60F3AQ38050626-9C869C18-E5BB-4126-87AE-2432C71E7A7EQ38137864-50AC8B21-F49F-4015-91F4-879805956287Q38259726-856ED3EB-BA60-4C2E-8F42-1895123D585EQ38470875-CEC74995-38A5-4BE4-95EB-3623C4F6D62CQ38542449-979D70BC-38F2-46EA-B4D7-B2574219AEC9Q38585777-36E03B6D-2BAB-42C5-BBFF-93282C31A884Q38635266-260B1EDA-0ECB-4495-88D3-7171B845EC86Q38705817-F5DBD110-B1E2-463B-9859-C52EE2FB6330Q38877461-A272990B-33E6-45A9-8CF9-F77AFECE5F04Q39255836-5FBF3229-CFAF-4B79-9582-3DEED8C44775Q39374978-D077A0D5-D9A1-4078-963A-660C75DDC810
P2860
Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
@en
Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
@nl
type
label
Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
@en
Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
@nl
prefLabel
Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
@en
Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
@nl
P2093
P1476
Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
@en
P2093
Johannes Waltenberger
Renu Virmani
Saami K Yazdani
Sebastiaan C A M Bekkers
P304
P356
10.1016/J.JACC.2009.12.037
P407
P577
2010-04-01T00:00:00Z